AbbVie
NORTH CHICAGO, IL
CISATRACURIUM BESYLATE PRESERVATIVE FREE (cisatracurium besylate) by AbbVie is end-plate to antagonize the action of acetylcholine, resulting in blockade of neuromuscular transmission. Approved for an adjunct to general anesthesia to facilitate tracheal intubation. First approved in 2019.
Drug data last refreshed 18h ago
end-plate to antagonize the action of acetylcholine, resulting in blockade of neuromuscular transmission. This action is antagonized by acetylcholinesterase inhibitors such as neostigmine .
Worked on CISATRACURIUM BESYLATE PRESERVATIVE FREE at AbbVie? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.